Klin Monbl Augenheilkd 2022; 239(05): 659-665
DOI: 10.1055/a-1710-3473
Übersicht

Viral Anterior Uveitis

Artikel in mehreren Sprachen: deutsch | English
Karoline Baquet-Walscheid
1   Augenzentrum am St. Franziskus-Hospital, Münster, Deutschland
2   Medizinische Fakultät der Universität Duisburg-Essen, Essen, Deutschland
,
Dominika Pohlmann
3   Charité – Campus Virchow-Klinik, Universitäts-Augenklinik, Berlin, Deutschland
4   Berliner Institut für Gesundheitsforschung, Berlin, Deutschland
,
3   Charité – Campus Virchow-Klinik, Universitäts-Augenklinik, Berlin, Deutschland
› Institutsangaben
Preview

Abstract

Differential diagnosis of viral anterior uveitis (AU) based on the typical clinical findings (anterior chamber inflammation, morphology of the keratic precipitates, severity of IOP increase in relapse) is often straightforward. When differential diagnosis is difficult clinically, analysis of aqueous humour by PCR and/or antibody testing (Goldmann-Witmer coefficient) may be helpful. While both modalities are highly specific, they lack absolute sensitivity. Patients with HSV, VZV and CMV associated uveitis require both antiviral as well as antiinflammatory medication and often additional antiglaucomatous therapy, depending on IOP. In contrast, specific antiviral treatment is not possible in rubella associated AU and steroids should be administered with extreme caution due to their adverse effects. With all subtypes of virus associated AU, recurrent episodes put the patients at risk of developing secondary glaucoma, which often requires surgical treatment.



Publikationsverlauf

Eingereicht: 01. November 2021

Angenommen: 26. November 2021

Artikel online veröffentlicht:
23. März 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany